Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety

INTRODUCTION: Real-world evidence on the effectiveness and safety of insulin degludec (IDeg) in patients with diabetes is a priority. We have therefore evaluated the effectiveness and safety of IDeg, including impact on metabolic control, glycemic variability, weight gain and hypoglycemia, in patien...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Ther
Auteurs principaux: Ponzani, Paola, Berra, Cesare, Di Lelio, Alessandra, Del Sindaco, Paola, Di Loreto, Chiara, Reggiani, Francesco, Lucisano, Giuseppe, Rossi, Maria Chiara
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965554/
https://ncbi.nlm.nih.gov/pubmed/31707573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-00722-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires